Scopolamine Transdermal System
3 NDCs across 1 manufacturer|3 Generic,0 Brand
Scopolamine Transdermal System is used to treat colonic diseases, diverticulitis, dysentery, facial paralysis, iridocyclitis and postencephalitic parkinson disease, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Scopolamine Transdermal System is available as 3 NDCs from 1 manufacturer (3 generic, 0 brand), with NADAC prices from $4.34 to $4.34 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
3G / 0B
Manufacturers
1
competing in market
Price Spread
$4.34 – $4.34
per EA
7d Activity
avg +0.0% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Padagis Israel Pharmaceuticals Ltd manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Anticholinergic class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing SCOPOLAMINE TRANSDERMAL SYSTEM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SCOPOLAMINE 1 MG/3 DAY PATCH | $4.3357 per EA | +0.02% |
SCOPOLAMINE 1 MG/3 DAY PATCH | $4.3357 per EA | +0.02% |
SCOPOLAMINE 1 MG/3 DAY PATCH | $4.3357 per EA | +0.02% |
Frequently Asked Questions
What is Scopolamine Transdermal System used to treat?
Scopolamine Transdermal System is used to treat colonic diseases, diverticulitis, dysentery, facial paralysis, iridocyclitis and postencephalitic parkinson disease, per the National Library of Medicine's MED-RT classification.
How many Scopolamine Transdermal System products are on the market?
The Scopolamine Transdermal System drug market contains 3 NDCs from 1 manufacturer — 3 generic and 0 brand products.
What is the price range for Scopolamine Transdermal System?
NADAC reference prices for Scopolamine Transdermal System range from $4.3357 to $4.3357 per EA.
Which manufacturers make Scopolamine Transdermal System?
1 manufacturer lists Scopolamine Transdermal System in NADAC. Ranked by number of NDCs, the largest are Padagis Israel Pharmaceuticals Ltd (3).
How has the price of Scopolamine Transdermal System changed recently?
Over the past 7 days, 3 Scopolamine Transdermal System NDCs rose and 0 fell, with a market-wide average change of +0.0%.